Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| ASML Holding NV | 2.08% | $1.43B | €346.61B | 38.18% | 78 Outperform | |
| SAP SE | 1.42% | $974.30M | €273.22B | 4.56% | 73 Outperform | |
| AstraZeneca | 1.30% | $893.14M | £192.33B | 7.56% | 75 Outperform | |
| Nestlé SA | 1.29% | $884.84M | CHF200.57B | 2.56% | 65 Neutral | |
| Novartis AG | 1.23% | $841.59M | CHF188.17B | 3.27% | 78 Outperform | |
| Roche Holding AG | 1.18% | $808.51M | CHF209.25B | 3.87% | 73 Outperform | |
| HSBC Holdings | 1.16% | $798.51M | £180.66B | 47.15% | 79 Outperform | |
| Shell (UK) | 1.10% | $757.77M | £163.15B | 14.14% | 77 Outperform | |
| Siemens | 1.09% | $747.27M | €192.86B | 35.64% | 74 Outperform | |
| Toyota Motor | 0.99% | $676.89M | ¥41.33T | 18.00% | 81 Outperform |